Inflammation, leukocytes and menstruation

Research output: Contribution to journalArticleOtherpeer-review

94 Citations (Scopus)


Menstruation has many of the features of an inflammatory process. The complexity and sequence of inflammatory-type events leading to the final tissue breakdown and bleeding are slowly being unravelled. Progesterone has anti-inflammatory properties, and its rapidly declining levels (along with those of estrogen) in the late secretory phase of each non-conception cycle, initiates a sequence of interdependent events of an inflammatory nature involving local inter-cellular interactions within the endometrium. Intracellular responses to loss of progesterone (in decidualized stromal, vascular and epithelial cells) lead to decreased prostaglandin metabolism and loss of protection from reactive oxygen species (ROS). Increased ROS results in release of NFκB from suppression with activation of target gene transcription and increased synthesis of pro-inflammatory prostaglandins, cytokines, chemokines and matrix metalloproteinases (MMP). The resultant leukocyte recruitment, with changing phenotypes and activation, provide further degradative enzymes and MMP activators, which together with a hypoxic environment induced by prostaglandin actions, lead to the tissue breakdown and bleeding characteristic of menstruation. In parallel, at sites where shedding is complete, microenvironmentally-induced changes in phenotypes of neutrophils and macrophages from pro- to anti-inflammatory, in addition to induction of growth factors, contribute to the very rapid re-epithelialization and restoration of tissue integrity.

Original languageEnglish
Pages (from-to)277-288
Number of pages12
JournalReviews in Endocrine & Metabolic Disorders
Issue number4
Publication statusPublished - Dec 2012
Externally publishedYes


  • Endometrial breakdown
  • Inflammation
  • Leukocyte
  • Matrix metalloproteinases
  • Menstruation
  • NFκB
  • Progesterone withdrawal
  • Prostaglandins

Cite this